Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant mice

Area of Science:

• Neuropharmacology
• GABAergic system research
• Benzodiazepine drug effects

Background:

• Benzodiazepines are commonly prescribed for anxiety and insomnia.
• Their mechanism of action involves modulating the GABA-A receptor complex.
• Understanding chronic effects on GABA receptor function is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the long-term effects of chronic flurazepam administration on GABA receptor function in mice.
• To assess alterations in the response to various GABAergic drugs after a 7-day flurazepam treatment.

Main Methods:

• Mice received daily intraperitoneal injections of flurazepam (40 mg/kg) for seven consecutive days.
• Effects on convulsion threshold, body temperature, and locomotor activity were measured 24 and 48 hours post-treatment.
• Responses to GABA receptor modulators including progabide, pentylenetetrazol, pentobarbitone, picrotoxin, and bicuculline were evaluated.

Main Results:

• Flurazepam significantly decreased the hypothermic and hypomobility effects of progabide at 48 hours.
• Convulsant actions of picrotoxin and bicuculline were reduced at 24 hours but not at 48 hours.
• Picrotoxin's convulsant effects increased at 48 hours, while hypothermic effects did not.

Conclusions:

• Chronic benzodiazepine treatment may decrease certain aspects of GABA receptor function 48 hours after the last dose.
• These observed functional changes do not fully explain previously reported increases in inverse agonist effects after chronic agonist treatment.
• Findings suggest complex, time-dependent alterations in GABA receptor pharmacology following sustained benzodiazepine exposure.